2.2 Collection Methods & Adverse Reactions
Key Takeaways
- Standard whole blood collection targets 450–500 mL (±10%) into an anticoagulant-preservative solution, and the draw should be completed quickly enough (generally under about 15 minutes) to preserve platelet and coagulation factor viability for component manufacturing
- Apheresis collection uses an automated cell separator and citrate-based anticoagulant to remove a target component while returning the remainder of the donor's blood
- Vasovagal syncope is the most common donor adverse reaction and is managed with positioning (legs elevated, head lowered), reassurance, and monitoring rather than medication in most cases
- Arterial puncture produces bright red, pulsatile blood and requires immediate needle removal with prolonged firm pressure, distinguishing it clearly from routine venous bleeding or hematoma
- Citrate toxicity is an apheresis-specific reaction caused by the anticoagulant transiently binding ionized calcium, producing perioral tingling and, if severe, tetany; it is managed by slowing the return rate and, if needed, giving calcium
Collection Methods & Adverse Reactions
Quick Answer: Whole blood is collected by venipuncture into a bag containing anticoagulant-preservative solution, targeting 450–500 mL within roughly 15 minutes to preserve component quality. Apheresis uses an automated cell separator with citrate anticoagulant to remove one component (plasma, platelets, or red cells) and return the rest of the donor's blood. The specialist must recognize and correctly manage the four classic donor reactions: vasovagal syncope, hematoma, arterial puncture, and citrate toxicity — each has a distinct presentation and a distinct first response.
Whole Blood Collection Mechanics
After site selection (typically the antecubital fossa) and antiseptic skin preparation — commonly a chlorhexidine-based or povidone-iodine-based scrub, with an iodine-free alternative available for iodine-sensitive donors — phlebotomy staff perform venipuncture into a closed, sterile collection system. Key operational parameters:
| Parameter | Standard | Why It Matters |
|---|---|---|
| Target volume | 450–500 mL ±10% (bag-dependent) | Matches the anticoagulant-preservative volume already in the bag; under- or over-collection skews the ratio |
| Collection time | Generally should be completed in well under 15 minutes | Prolonged collection allows early clot activation, degrading platelets and coagulation factors needed for component products |
| Mixing | Continuous or intermittent gentle agitation during draw | Ensures even distribution of anticoagulant throughout the unit as it fills |
| Anticoagulant-preservative | CPD, CP2D, or CPDA-1 depending on bag system | Chelates calcium to prevent clotting and buffers pH/nutrients to extend red cell shelf life |
A unit collected too slowly is not necessarily discarded outright, but facilities commonly restrict such units from being used to manufacture components that depend on intact platelet or coagulation factor function (for example, platelet concentrates), because the extended time at ambient temperature before adequate mixing/cooling allows early activation.
Apheresis Collection Mechanics
Apheresis instruments withdraw whole blood, anticoagulate it immediately with an acid-citrate-dextrose solution (commonly ACD-A), separate it by centrifugation into layers, retain the targeted component (plasma, platelets, or red cells, alone or in combination), and return the remaining components to the donor — either continuously through a second line (two-needle systems) or in alternating draw/return cycles through a single line (single-needle systems). Because the donor's blood is continuously exposed to citrate anticoagulant and a portion returns to circulation, apheresis introduces a reaction category not seen in whole blood collection: citrate toxicity (discussed below).
Donor Adverse Reactions
| Reaction | Typical Presentation | Immediate Management |
|---|---|---|
| Vasovagal syncope | Pallor, diaphoresis, hypotension, bradycardia, lightheadedness, or frank loss of consciousness; often triggered by anxiety or the sight of blood/needle | Stop the draw if still in progress, lower the donor's head below heart level or elevate the legs (Trendelenburg-type positioning), apply a cool compress, loosen restrictive clothing, and monitor vitals until resolved |
| Hematoma | Localized swelling and bruising at the venipuncture site from blood leaking into surrounding tissue, usually from a through-and-through puncture or incomplete vessel entry | Remove the needle, apply firm direct pressure, elevate the arm, apply cold compress if needed to limit swelling |
| Arterial puncture | Bright red blood, pulsatile flow (often filling the tubing/bag unusually fast), donor may report a distinct pain sensation | Stop the draw immediately, remove the needle, apply firm continuous pressure for an extended period (generally at least 10 minutes), keep the arm elevated, and document/monitor per facility policy — do not attempt to "push through" or reposition the needle |
| Citrate toxicity | Perioral or peripheral tingling/numbness, and in more severe cases muscle twitching or tetany, from citrate transiently chelating ionized calcium during apheresis | Slow or temporarily pause the return/draw rate to reduce citrate infusion rate; give oral calcium for mild symptoms; escalate to medical evaluation and, in significant cases, IV calcium gluconate |
Distinguishing arterial puncture from hematoma is a frequent exam focus: both involve unwanted bleeding at the site, but arterial puncture is identified by the color and pulsatile pattern of the blood (bright red, pulsing with the heartbeat) rather than by swelling alone, and it demands a longer, firmer, uninterrupted pressure application because arterial pressure is far higher than venous pressure and will reopen a site closed with only brief pressure.
Distinguishing citrate toxicity from vasovagal syncope is another key discrimination: citrate toxicity is specific to apheresis (it does not occur with routine whole blood donation, since the anticoagulant in a whole blood bag is not infused back into the donor), and its hallmark symptom is perioral/peripheral paresthesia related to transient hypocalcemia rather than the global hypotensive, presyncopal picture of a vasovagal episode. A donor can, of course, experience both reaction types across different aspects of the same apheresis procedure, so careful symptom-by-symptom assessment matters more than assuming a single diagnosis.
Reaction Severity and Documentation
Facilities generally classify reactions by severity (for example, mild, moderate, severe) to guide the intensity of the response and any post-reaction restrictions on future donation (some reactions prompt temporary deferral until resolved, or a note in the donor record to modify technique on future visits, such as choosing a different arm or using a smaller needle after a prior arterial puncture). Reaction rates and types are also tracked as part of a facility's hemovigilance program, which monitors adverse events across the collection process to identify trends (for example, a rise in vasovagal reactions in first-time or young donors) and drive process improvements such as pre-donation hydration reminders or adjusted staffing during peak collection times.
Why This Matters for the Exam
ASCP specialist-level items in this domain typically present a brief clinical vignette (symptom description, timing, apheresis vs. whole blood context) and ask you to (1) identify the reaction, and (2) select the correct immediate action. The fastest way to answer correctly is to anchor on the most distinctive clue in the stem — blood color/pulsatility points to arterial puncture, perioral tingling during apheresis points to citrate toxicity, and global hypotension/pallor points to vasovagal syncope — rather than trying to memorize an exhaustive symptom list for each.
During a plateletpheresis procedure, a donor reports perioral tingling and mild tingling in the fingertips. What is the most likely cause and the most appropriate initial response?
A phlebotomist notices that blood filling the collection bag is unusually bright red and appears to pulse with the donor's heartbeat. What should happen next?
Which factor most directly limits how long a whole blood collection should take before it is considered too slow for standard component manufacturing?